Nanobiotix S.A.
IPOBuilding new cancer therapies atom by atom | Nanobiotix
Public · Paris, France · $14.6M raised
- Headquarters
- Paris
- Employees
- 51–200
- Business Model
- B2B
- Website
- nanobiotix.com
- Total Funding
- $14.6M
- Last Round
- $4.8M Corporate RoundDec 2023
- Rounds
- 3
- Type
- Public
About
French clinical-stage nanotech company developing hafnium oxide nanoparticle NBTXR3 to amplify radiotherapy effects in cancer tumors.
Summary
Nanobiotix S.A. is a Biotech company based in Paris, France. It has raised $14.6M in total across 3 rounds, most recently a $4.8M Corporate Round round in Dec 2023. Investors include Healthcare Royalty Partners and Johnson & Johnson Innovation.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2025
Sign up to see all 7 rounds
Secondary Market through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nanobiotix-s-a"><img src="https://indexed.vc/api/badge/company/nanobiotix-s-a" alt="Nanobiotix S.A. on Indexed.vc" width="260" height="76" /></a>